Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
Search fresh public links, source activity, and ready-to-use post angles for Colossal Biosciences.
Fresh curated links around Colossal Biosciences are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
Colossal Biosciences claims to have brought back the dire wolf, and is now hard at work on its quest to resurrect several other species, including the woolly mammoth and the moa, a...
Traditionally focused on research tools for academic, government, and industry customers, 10x has moved this year to launch clinical collaborations with top-tier institutions—the m...
HeartBeat.bio and Cubase Bio are combining cardiac organoids with 3D spatial transcriptomics and RNA sequencing to study...
Program expected to commence in Q4 2026 and establish a roadmap for larger-scale production in 2027
The Flatiron Park facility in Colorado will serve as the Watchmaker Boulder Manufacturing Center of Excellence for reagent manufacturing and will house the company’s manufacturing,...
Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplante...
Strategic Financing to Accelerate Exosome Pipeline Expansion, International Joint Ventures, and Scale-Up of NexTel Medical (MAJI)
Engineered a DHB prodrug-based oral nano-emulsion with enhanced bioavailability, dramatically improving the efficacy of immune checkpoint blockade therapy.
The collaboration brings together Celonic’s expertise in cell line development, drug substance process development, intensified bioprocessing, and GMP manufacturing with Leukocare’...
This AI startup, which lists Nobel laureate David Baker among its co-founders, has announced a “world model” of a cell that can simulate both its natural state and […]
The founders of contract research organization Quartesian have reunited to form Acrosian, a CRO designed to be purpose-built for the AI era.
Expanded RNA sequencing services at Novogene Europe bring advanced single-cell transcriptomics, bioinformatics, and multiomics support closer to UK researchers studying complex bio...
Twist Bioscience’s integrated ecosystem of next-generation sequencing tools that drive up throughput and lower cost is powering a new era of population genetics research.
Waterloo, Ontario-based startup High Q Technologies has announced a global commercial partnership with Creative Biostructure, a Shirley, New York-based contract research organizati...
New 3D Readyâ„¢ Cardioid Supplement Kits combine advanced cardiac organoid biology and automated workflows to help researchers generate more reproducible, scalable cardiac models f...
Rather than generating new wet-lab data for every compound, DeepCyte trains a foundation model that is capable of predicting toxicity mechanisms for compounds that it has never mea...
Contract research organization Icon announced a multi-year collaboration with Anthropic this week to bring Claude’s AI capabilities to clinical trials.
Because intismeran autogene is a personalized cancer therapy made for each patient based on the individual genetic mutations of their tumors, the Merck-Moderna stock surge extended...
Roche’s Genentech is paying DualityBio $45 million upfront for rights to antibody-drug conjugates (ADCs) designed for the growing pool of patients who progress after treatment with...
The expanded next-generation sequencing offering from Clean Cells now covers GMP-compliant viral safety testing for viral vectors and recombinant preparations, building on existing...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.